A client signing a contract with a consultant.

Why Appointing a Regulatory Consultant as Your Authorised Representative in Singapore Improves Submission Success


Key Takeaways

  • Appointing the right authorised representative in Singapore is a regulatory necessity, not just a formality.
  • A regulatory advisor ensures compliance with Health Sciences Authority (HSA) guidelines and streamlines various application processes.
  • Strong communication with HSA prevents delays and improves approval success rates.
  • Accurate document management and post-market compliance safeguard long-term product success.
  • Overseas companies without a local office need a trusted marketing authorisation holder in Singapore.

Introduction

With Singapore’s stringent regulatory environment and active enforcement by HSA, appointing the right authorised representative is a critical decision. The right partner ensures your dossier  is submission-ready, timelines stay on track, and post-market obligations are met. The wrong choice, on the other hand, can result in costly delays, refusals, or even penalties. 

For overseas companies navigating overseas pharma regulations, working with an experienced local regulatory consultant can mean the difference between a smooth approval and a failed submission. Here’s why.

1. Local Knowledge and HSA Familiarity

A regulatory consultant with local expertise provides an in-depth understanding of HSA guidelines and the latest updates. This is particularly important when preparing a new drug application or biologics licence application, where product-specific nuances can affect approval timelines.

For example, it is essential to determine the comparator source and also the type of bridging data required for a biosimilar application. A local regulatory consultant could support by helping companies to identify the gaps hence minimising the queries raised during screening which  will shorten lead time. 

Additionally, there have been recent updates to therapeutic product registration guidelines in Singapore, including stricter proof of GMP compliance for  drug substance  manufacturing sites and enhanced criteria for forensic classification of therapeutic products. By appointing an authorised representative familiar with these changes, you can ensure that your product registration strategy stays compliant from the outset. 

2. Streamlined Communication with Authorities

Your authorised representative is the official point of contact with the HSA, handling every query and making clarifications on your behalf. The speed and accuracy of these responses can mean the difference between a three-month review and a nine-month delay.

Queries from the HSA often focus on areas such as stability data, safety reports, or labelling requirements. A regulatory affairs consultant who understands the HSA’s expectations can resolve such issues quickly; for instance, addressing local submission requirements early in the gap analysis exercise can prevent unwanted delay and rejection during screening. By contrast, international companies without local expertise may struggle to interpret requests, leading to costly delays.

3. Document Management and Submission Accuracy

In Singapore, product registration also requires strict adherence to HSA’s e-submission platforms and formats, such as the e-CTD or the ASEAN Common Technical Dossier (ACTD) formats. Small errors, like missing appendices, incorrect file naming, or broken hyperlinks, can result in rejections or lengthy rework.

A trusted consultant providing pharma regulatory services ensures every document meets technical requirements while maintaining a centralised, version-controlled repository. This prevents conflicting submissions, reduces the risk of non-compliance, and demonstrates professionalism to regulators. 

4. Post-Market Compliance

Approval is only the beginning. Once your therapeutic product, medical device, or biologic is on the market, ongoing obligations remain. These include mandatory vigilance reporting, submission of adverse event data, and regular updates through periodic safety update reports (PSURs).

By appointing a regulatory consultant as your authorised representative, these obligations are monitored and managed consistently. This proactive approach reduces the risk of penalties, product recalls, or even suspension of approval, safeguarding both compliance and market trust.

5. Trusted Point of Contact for Overseas Manufacturers

Two businesspeople shaking hands for a partnership.

For companies without an office in Singapore, an authorised representative is not only valuable but also legally required. In practice, this entity acts as your marketing authorisation holder (MAH)—your officially recognised local legal presence responsible for regulatory compliance. The MAH handles official correspondence, notices, and all obligations with the HSA on your behalf.

In the event of recalls, withdrawals, or urgent label changes, they will provide the logistical and regulatory coordination needed to respond quickly. This partnership gives overseas manufacturers peace of mind, knowing their products are managed by experts who understand the local pharmaceutical landscape.

Risks of Not Having a Local Authorised Representative

Without an authorised representative in Singapore, regulatory submissions and filing would be a tedious process. Beyond that, missed HSA queries can lead to automatic rejection, while the absence of monitoring increases the likelihood of enforcement actions.

For example, failing to act on an HSA-mandated label update could result in penalties. Similarly, without a local partner, managing recalls or responding to safety issues becomes significantly harder. This exposes companies to regulatory risk, market delays, and reputational damage.

Conclusion

In Singapore’s highly regulated market, your authorised representative is both your regulatory gatekeeper and your compliance safeguard. Appointing a regulatory consultant as your authorised representative ensures your submissions are handled with precision and strategic foresight.

At The Reg Consultants (TRC), we provide comprehensive HSA registration and regulatory support in Singapore, designed to guide international manufacturers through every step. We’ll help you navigate complex requirements, avoid unnecessary delays, and maintain compliance long after approval. With us, you gain not only a legal requirement but also a trusted partner committed to your long-term success.

Contact us today to learn more. 

  • Share This Article:

Hand picking pharmaceutical product for regulatory consulting in pharma

If you have any specific regulatory questions pertaining to entering the Singapore market or require assistance with pharma regulatory services and medical product registration, feel free to reach out. Your success in the pharmaceutical industry starts with us!

We use cookies to ensure you get the best experience on our website.